Recognizing that cell surface-localized PD-L1 on tumor cells engages PD-1 on T cells to inhibit antitumor responses, we further quantified cell surface PD-L1 using flow cytometry and immunofluorescence in A375 and B16-F10 melanoma cells. This evidence concerns the gene CD274 and neoplasm.